Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Clinical Investigation|February 25, 2021
Management of LDL-cholesterol levels in patients with Diabetes Mellitus in Cardiology Practice: Real-life evidence of Under-treatment from the EPHESUS registryKadir Uğur Mert, Özcan Başaran, Gurbet Özge Mert, et al.International Journal of Clinical Practice|May 1, 2019
The reasons of poor lipid target attainment for secondary prevention in real life practice: Results from EPHESUSGurbet Özge Mert, Özcan Başaran, Kadir Uğur Mert, et al.Bosnian Journal of Basic Medical Sciences|October 3, 2017
Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR studySadık Volkan Emren, Mehdi Zoghi, Rida Berilgen, et al.ESC Heart Failure|September 28, 2024
Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART studyUmut Kocabas, Isil Ergin, Veysel Yavuz, et al.Anatolian Journal of Cardiology|February 7, 2023
How Did the Updated 2019 European Society of Cardiology/European Atherosclerosis Society Risk Categorization for Patients with Diabetes Affect the Risk Perception and Lipid Goals? A Simulated Analysis of Real-life Data from EPHESUS StudyÖzcan Başaran, Volkan Doğan, Kadir Uğur Mert, et al.Anatolian Journal of Cardiology|July 7, 2020
Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA studyUmut Kocabaş, Tarık Kıvrak, Gülsüm Meral Yılmaz Öztekin, et al.Journal of Clinical Lipidology|December 10, 2023
Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registryMeral Kayıkcioglu, Özcan Başaran, Volkan Doğan, et al.Clinical Cardiology|January 28, 2025
Incidence and Predictors of Clinical Outcomes in Real-Life Patients With Atrial Fibrillation Treated With Oral Factor Xa Inhibitors: The Follow-Up Results of the ANATOLIA-AF StudyUmut Kocabaş, Isil Ergin, Sadi Can Sönmez, et al.Arquivos Brasileiros De Cardiologia|November 28, 2024
Fixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease in Turkish Population: DAPT-TRAhmet Öz, Kenan Toprak, Ertan Aydin, et al.Pageof 2